Pharma News

Bringing Neuroplastogens to the Window: Q&A With Delix CEO Mark Rus

Photo of MEEFRO MEEFRO Send an email March 5, 2024
0 124,533 Less than a minute

Rus discusses his company’s work with neuroplastogens and how they differ from similar, psychedelic treatments.

Source link
#Bringing #Neuroplastogens #Window #QampA #Delix #CEO #Mark #Rus

Photo of MEEFRO MEEFRO Send an email March 5, 2024
0 124,533 Less than a minute
Photo of MEEFRO

MEEFRO

Related Articles

What is the current valuation of AstraZeneca’s Sabestomig

April 16, 2024

What is the current valuation of AbbVie’s ABBV-400

April 16, 2024

What is the current valuation of Merck’s MK-1084

April 16, 2024

What is the current valuation of AstraZeneca’s AZD-9574

April 16, 2024

Leave a Reply

Your email address will not be published. Required fields are marked *